Delivery Order SPE2DE23D0008-SPE2D626F41FT
Award Date 2/3/26
Potential Completion Date 2/5/26
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Irvine, CA 92612, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order on February 3, 2026, for Natrelle Inspira SSF 265cc breast implants with an ultimate completion date of February 5, 2026. The contract is funded through the Medical Supply Chain division of the Defense Logistics Agency and will be performed in Irvine, California. This award was not designated as a set-aside contract, reflecting Allergan's position as a sole-source provider of specialized breast...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 delivery order by the Defense Logistics Agency's Medical Supply Chain division for Natrelle Inspira SSF 450cc breast implants. This fixed-price contract with economic price adjustment was executed on February 3, 2026, with an ultimate completion date of February 6, 2026, and carries no set-aside designation. The product will be delivered to Irvine, California, reflecting Allergan's established role as a sole-source supplier...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,850 fixed-price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical on November 6, 2025, for Natrelle Inspira SSM 405CC breast implants. The contract, which represents a child delivery order under a larger Indefinite Delivery Vehicle (IDV), is scheduled for completion by November 24, 2025, and will be performed at the contractor's facility in Irvine, California. The award carries no set-aside designation,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $5,421.00 fixed-price delivery order contract by the Defense Logistics Agency Medical Supply Chain on July 21, 2025, for Natrelle Inspira SSM 210CC breast implants. The contract, which carries an ultimate completion date of July 23, 2025, will be performed at Allergan's facility in Irvine, California. This delivery order was awarded without set-aside designation, reflecting Allergan's status as the sole-source provider of these...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order with economic price adjustment on September 2, 2025, for Natrelle Inspira SCM 375CC breast implants. The contract, which carries an ultimate completion date of September 4, 2025, was funded by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical medical devices. The place of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $20,856 fixed-price delivery order on October 30, 2025, for Natrelle Inspira SSF 745CC breast implants. This is a child contract under a larger Indefinite Delivery/Indefinite Quantity (IDV) vehicle—a $13.5 million Natrelle breast implants and surgical devices contract established with the Defense Logistics Agency Troop Support Medical on December 8, 2022. The delivery order carries a completion deadline of November 3, 2025, with...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Medical Supply Chain division of the Defense Logistics Agency on July 24, 2025, for Natrelle Inspira SSM 445CC breast implants. This fixed-price delivery order with economic price adjustment represents a child award issued without set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical implants to the federal government. The order is scheduled...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $4,635.00 on February 3, 2026, for Natrelle Inspira SCLP 320cc breast implants. This fixed-price contract with economic price adjustment carries an ultimate completion date of February 6, 2026, and will be performed in Irvine, California. The award was made without a set-aside designation, reflecting Allergan's status as a sole-source provider of these specialized medical devices. Funding for this delivery...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a fixed-price delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on November 26, 2025, with completion scheduled for December 1, 2025. The contract covers the delivery of Natrelle Inspira SCM 485CC breast implants to support surgical procedures at military treatment facilities and related federal healthcare systems. This delivery order was issued without a set-aside designation, reflecting...
- Allergan USA Inc., a subsidiary of AbbVie Inc., received a $1,200 fixed-price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical on January 15, 2026, for Natrelle Inspira SSM 520cc breast implants. This is a child contract under one of Allergan's two significant Indefinite Delivery Vehicle (IDV) contracts valued at $13.5 million for Natrelle breast implants and surgical devices, established December 8, 2022. The delivery order carries an ultimate completion date of...